Ordering
Available Variants25 mg
CHA.38019-25mg
Price
€142.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.38019-25mg | €142.40 |
phyproof® Reference Substance
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C6H9NO2 · HCl |
|---|---|
| CAS Number | 6027-91-4 |
| Molecular Weight | 163.60 |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| MDL number | MFCD00055191 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319,H335 |
| pcodes | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Guvacine hydrochloride, with a CAS number of 6027-91-4, is a synthetic compound that has garnered significant attention in the realm of pharmacology and neuroscience. As a potent inhibitor of the glycine transporter type 1, guvacine hydrochloride has been extensively studied for its potential therapeutic applications, particularly in the treatment of neurological disorders. Research has demonstrated that this compound can effectively increase glycine concentrations in the synaptic cleft, thereby enhancing inhibitory neurotransmission. The resulting augmentation of glycinergic activity has been implicated in various physiological processes, including the modulation of pain perception, anxiety, and memory. Consequently, guvacine hydrochloride has emerged as a promising candidate for the development of novel therapeutic strategies targeting glycine-mediated neurotransmission, with potential implications for the management of a range of neurological and psychiatric conditions. Its mechanism of action continues to be the subject of ongoing scientific investigation.
